Literature DB >> 23868745

Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity.

Yu-cheng Wang1, Yuying Li, Xin-yi Wang, Duo Zhang, Huihui Zhang, Qi Wu, Yu-qing He, Jian-ying Wang, Lian Zhang, Hongfeng Xia, Jun Yan, Xihua Li, Hao Ying.   

Abstract

AIMS/HYPOTHESIS: Adipose tissue is a dynamic endocrine organ that regulates whole-body energy homeostasis through the secretion of signalling molecules. Recent reports suggest that secreted microRNAs (miRNAs) may function as biologically active molecules for intercellular communication. This study aims to identify obesity-related circulating miRNA that could be secreted from adipocytes and to explore its possible role in the pathogenesis of metabolic diseases.
METHODS: Real-time RT-PCR was used to evaluate the circulating level of miR-130b in mouse models of obesity as well as in humans. Luciferase assay and immunoblotting were used to verify the miRNA target. The effect of miR-130b on mouse peroxisome proliferator-activated receptor γ coactivator-1α was also investigated by electrogene transfer.
RESULTS: The circulating level of miR-130b was elevated in mouse models of obesity as well as in obese Chinese individuals. More interestingly, the circulating level of miR-130b was positively correlated with BMI. Moreover, circulating miR-130b was a better predictor of the metabolic syndrome than was triacylglycerol level. Mechanistically, adipocytes secreted miR-130b during adipogenesis. TGF-β, which is proportionately increased with obesity, stimulated miR-130b secretion from adipocytes. Furthermore, miR-130b was able to target muscle cells and reduce the expression of its direct target gene, PGC-1α (also known as PPARGC1A), which plays a key role in lipid oxidation in muscle. CONCLUSIONS/
INTERPRETATION: Circulating miR-130b reflects the degree of obesity and could serve as a potential biomarker for hypertriacylglycerolaemia and metabolic syndrome. Circulating miR-130b could function as a metabolic mediator for adipose-muscle crosstalk and might be involved in the pathogenesis of obesity-associated metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23868745     DOI: 10.1007/s00125-013-2996-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

Review 1.  Horizontal transfer of microRNAs: molecular mechanisms and clinical applications.

Authors:  Xi Chen; Hongwei Liang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

3.  Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.

Authors:  Hariom Yadav; Celia Quijano; Anil K Kamaraju; Oksana Gavrilova; Rana Malek; Weiping Chen; Patricia Zerfas; Duan Zhigang; Elizabeth C Wright; Christina Stuelten; Peter Sun; Scott Lonning; Monica Skarulis; Anne E Sumner; Toren Finkel; Sushil G Rane
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

Review 4.  Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.

Authors:  Ke Zen; Chen-Yu Zhang
Journal:  Med Res Rev       Date:  2010-11-09       Impact factor: 12.944

5.  Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China.

Authors:  Y Wang; J Mi; X-Y Shan; Q J Wang; K-Y Ge
Journal:  Int J Obes (Lond)       Date:  2006-05-02       Impact factor: 5.095

Review 6.  Adipokines and the peripheral and neural control of energy balance.

Authors:  Rexford S Ahima; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2008-01-17

7.  Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese.

Authors:  Liang Sun; Oscar H Franco; Frank B Hu; Lu Cai; Zhijie Yu; Huaixing Li; Xingwang Ye; Qibin Qi; Jing Wang; An Pan; Yong Liu; Xu Lin
Journal:  J Clin Endocrinol Metab       Date:  2008-09-16       Impact factor: 5.958

8.  Genome-wide profiling of microRNAs in adipose mesenchymal stem cell differentiation and mouse models of obesity.

Authors:  Lena Bengestrate; Sam Virtue; Mark Campbell; Antonio Vidal-Puig; Dirk Hadaschik; Peter Hahn; Wolfgang Bielke
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

9.  Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.

Authors:  María Mittelbrunn; Cristina Gutiérrez-Vázquez; Carolina Villarroya-Beltri; Susana González; Fátima Sánchez-Cabo; Manuel Ángel González; Antonio Bernad; Francisco Sánchez-Madrid
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  45 in total

Review 1.  Novel Mediators of Adipose Tissue and Muscle Crosstalk.

Authors:  Ira Indrakusuma; Henrike Sell; Jürgen Eckel
Journal:  Curr Obes Rep       Date:  2015-12

2.  Perivascular adipose tissue-derived extracellular vesicle miR-221-3p mediates vascular remodeling.

Authors:  Xinzhi Li; Laurel L Ballantyne; Ying Yu; Colin D Funk
Journal:  FASEB J       Date:  2019-08-30       Impact factor: 5.191

Review 3.  Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease.

Authors:  Marcelo A Mori; Raissa G Ludwig; Ruben Garcia-Martin; Bruna B Brandão; C Ronald Kahn
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

4.  Plasma MicroRNA signature predicting weight gain among Mexican-American women.

Authors:  Hua Zhao; Jie Shen; Carrie Daniel-MacDougall; Xifeng Wu; Wong-Ho Chow
Journal:  Obesity (Silver Spring)       Date:  2017-03-25       Impact factor: 5.002

Review 5.  Uncovering epigenetic landscape: a new path for biomarkers identification and drug development.

Authors:  Daiane Teixeira de Oliveira; Renata Guerra-Sá
Journal:  Mol Biol Rep       Date:  2020-10-21       Impact factor: 2.316

Review 6.  Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome.

Authors:  C Ronald Kahn; Guoxiao Wang; Kevin Y Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

7.  Ethanol-Impaired Myogenic Differentiation is Associated With Decreased Myoblast Glycolytic Function.

Authors:  Danielle E Levitt; Naveena Chalapati; Matthew J Prendergast; Liz Simon; Patricia E Molina
Journal:  Alcohol Clin Exp Res       Date:  2020-10-03       Impact factor: 3.455

8.  Role of microRNA-130b in placental PGC-1α/TFAM mitochondrial biogenesis pathway.

Authors:  Shaoning Jiang; April M Teague; Jeanie B Tryggestad; Steven D Chernausek
Journal:  Biochem Biophys Res Commun       Date:  2017-04-19       Impact factor: 3.575

9.  Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.

Authors:  Ying Shao; Huiwen Ren; Chuan Lv; Xiaoyu Ma; Can Wu; Qiuyue Wang
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

10.  Influence of gestational diabetes mellitus on human umbilical vein endothelial cell miRNA.

Authors:  Jeanie B Tryggestad; Anu Vishwanath; Shaoning Jiang; Ashwini Mallappa; April M Teague; Yusuke Takahashi; David M Thompson; Steven D Chernausek
Journal:  Clin Sci (Lond)       Date:  2016-08-25       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.